MarketPeel
Insider Trading Intelligence
EM

Eduardo Bruno Martins

SGMT
CHIEF MEDICAL OFFICER · SAGIMET BIOSCIENCES INC. · CIK 0001670431
FILING MIX · LIFETIME58%/42%
BUYS
7
SELLS
5
TOTAL VALUE
$121.0K
COMPANIES
1
ACTIVE SINCE
Jul 2023
HOLDINGS NOW
88,000
AVG SELL PX
$5.97
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Eduardo Bruno Martins, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+33.33%+5.95%-0.29%+6.24%+11.51%
14d3+66.67%+0.01%-1.08%+1.08%+2.28%
30d3+100.00%-10.91%-0.12%-10.80%-10.67%
60d3+66.67%-7.60%+2.10%-9.70%-4.20%
90d3+33.33%+33.26%+6.66%+26.60%+29.53%
180d3(1 pending)+50.00%+2.24%+9.34%-7.09%-7.09%
1y3(2 pending)+0.00%+204.53%+15.40%+189.13%+189.13%
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SGMT · 88,000 shares · as of Feb 19, 2026
049,53399,066148,599198,132202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 7 buys / 5 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SGMT
SAGIMET BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
44,000147,296Feb 19, 2026Feb 20, 2026View →
SGMT
SAGIMET BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
88,00088,000Feb 19, 2026Feb 20, 2026View →
SGMT
SAGIMET BIOSCIENCES INC.
SALE
Chief Medical Officer
3,640$5.36$19.5K103,296Feb 10, 2026Feb 12, 2026View →
SGMT
SAGIMET BIOSCIENCES INC.
SALE
Chief Medical Officer
8,277$9.13$75.6K106,936Jul 21, 2025Jul 23, 2025View →
SGMT
SAGIMET BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
138,000138,000Feb 6, 2025Feb 7, 2025View →
SGMT
SAGIMET BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
34,000115,213Feb 6, 2025Feb 7, 2025View →
SGMT
SAGIMET BIOSCIENCES INC.
SALE
Chief Medical Officer
8,357$3.10$25.9K81,213Jul 19, 2024Jul 23, 2024View →
SGMT
SAGIMET BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
89,57089,570Nov 17, 2023Nov 21, 2023View →
SGMT
SAGIMET BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
44,00944,009Jul 18, 2023Jul 20, 2023View →
SGMT
SAGIMET BIOSCIENCES INC.
SALE
Chief Medical Officer
44,0090Jul 18, 2023Jul 20, 2023View →
SGMT
SAGIMET BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
198,132198,132Jul 18, 2023Jul 20, 2023View →
SGMT
SAGIMET BIOSCIENCES INC.
SALE
Chief Medical Officer
198,1320Jul 18, 2023Jul 20, 2023View →
Other insiders · SGMT
Loading peer insiders…
About this filer
CIK 0001670431
ROLE
Chief Medical Officer
PRIMARY
SGMT
COMPANIES
1
ACTIVE SINCE
Jul 2023
MARKETPEEL · /INSIDER/0001670431DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback